Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (1999) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Toxicology, Supplement | journal | 0.138 Q3 | 7 | 1 | 40 | 389 | 16 | 40 | 0.40 | 389.00 |  |
| 2 | Critical Reviews in Toxicology | journal | 2.039 Q1 | 129 | 13 | 53 | 2887 | 295 | 52 | 4.58 | 222.08 | |
| 3 | Natural Product Reports | journal | 2.402 Q1 | 211 | 42 | 96 | 6961 | 435 | 96 | 4.50 | 165.74 | |
| 4 | Expert Opinion on Therapeutic Targets | journal | 0.123 Q4 | 106 | 40 | 118 | 4160 | 9 | 116 | 0.08 | 104.00 | |
| 5 | Expert Opinion on Investigational Drugs | journal | 0.348 Q2 | 117 | 155 | 426 | 12075 | 435 | 418 | 1.06 | 77.90 | |
| 6 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 0.608 Q2 | 99 | 12 | 14 | 900 | 30 | 14 | 2.14 | 75.00 | |
| 7 | Advances in Antiviral Drug Design | book series | 1.023 Q1 | 12 | 7 | 7 | 519 | 23 | 5 | 0.00 | 74.14 | |
| 8 | Clinical Pharmacokinetics | journal | 1.586 Q1 | 184 | 81 | 186 | 5697 | 1014 | 178 | 5.21 | 70.33 | |
| 9 | Drug Safety | journal | 0.795 Q1 | 140 | 92 | 208 | 6358 | 598 | 202 | 2.83 | 69.11 | |
| 10 | Expert Opinion on Emerging Drugs | journal | 0.264 Q3 | 54 | 20 | 43 | 1380 | 34 | 42 | 0.79 | 69.00 | |
| 11 | BioDrugs | journal | 0.226 Q3 | 79 | 79 | 272 | 5247 | 182 | 257 | 0.65 | 66.42 | |
| 12 | Toxicology and Industrial Health | journal | 0.376 Q3 | 69 | 73 | 158 | 4477 | 177 | 157 | 1.20 | 61.33 | |
| 13 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.197 Q3 | 25 | 15 | 51 | 919 | 35 | 40 | 0.79 | 61.27 | |
| 14 | Current Opinion in Molecular Therapeutics | journal | 67 | 93 | 0 | 5163 | 0 | 0 | 0.00 | 55.52 | | |
| 15 | Expert Opinion on Pharmacotherapy | journal | 93 | 16 | 0 | 861 | 0 | 0 | 0.00 | 53.81 | | |
| 16 | Toxin Reviews | journal | 0.205 Q4 | 54 | 24 | 93 | 1269 | 57 | 88 | 0.60 | 52.88 | |
| 17 | Cytokines, Cellular and Molecular Therapy | journal | 0.670 Q1 | 28 | 26 | 56 | 1337 | 101 | 55 | 1.80 | 51.42 | |
| 18 | Antiviral Chemistry and Chemotherapy | journal | 0.497 Q2 | 59 | 32 | 176 | 1616 | 306 | 175 | 1.79 | 50.50 | |
| 19 | Neuropsychopharmacology | journal | 2.634 Q1 | 249 | 176 | 309 | 8662 | 1624 | 291 | 4.69 | 49.22 | |
| 20 | Neuropharmacology | journal | 2.249 Q1 | 191 | 182 | 563 | 8527 | 2242 | 556 | 4.05 | 46.85 | |
| 21 | International Journal of Neuropsychopharmacology | journal | 0.324 Q2 | 125 | 40 | 26 | 1850 | 20 | 26 | 0.77 | 46.25 | |
| 22 | Trends in Pharmacological Sciences | journal | 4.514 Q1 | 244 | 102 | 304 | 4699 | 2317 | 233 | 8.20 | 46.07 | |
| 23 | Current Opinion in Drug Discovery and Development | journal | 1.523 Q1 | 85 | 68 | 15 | 3096 | 67 | 15 | 4.47 | 45.53 | |
| 24 | Receptors and Channels | journal | 1.182 Q1 | 44 | 21 | 78 | 923 | 148 | 78 | 1.65 | 43.95 | |
| 25 | IDrugs : the investigational drugs journal | journal | 0.237 Q3 | 39 | 183 | 58 | 7804 | 20 | 58 | 0.34 | 42.64 | |
| 26 | Expert Opinion on Therapeutic Patents | journal | 0.356 Q2 | 88 | 143 | 398 | 6018 | 323 | 394 | 1.02 | 42.08 | |
| 27 | Toxicological Sciences | journal | 0.332 Q3 | 207 | 212 | 482 | 8424 | 871 | 477 | 1.57 | 39.74 | |
| 28 | Environmental Pollution | journal | 1.028 Q1 | 301 | 167 | 607 | 6619 | 799 | 604 | 1.16 | 39.63 | |
| 29 | PharmacoEconomics | journal | 0.533 Q2 | 118 | 134 | 438 | 5226 | 626 | 403 | 1.41 | 39.00 | |
| 30 | Tumor Targeting | journal | 0.664 Q1 | 10 | 32 | 22 | 1183 | 41 | 21 | 1.86 | 36.97 | |
| 31 | Tetrahedron | journal | 1.333 Q1 | 236 | 1153 | 3787 | 42360 | 8137 | 3780 | 2.17 | 36.74 | |
| 32 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.340 Q2 | 57 | 32 | 114 | 1171 | 61 | 106 | 0.58 | 36.59 | |
| 33 | Journal of Peptide Science | journal | 0.517 Q2 | 73 | 58 | 128 | 2119 | 150 | 128 | 1.26 | 36.53 | |
| 34 | Mutagenesis | journal | 0.655 Q1 | 102 | 89 | 267 | 3251 | 550 | 264 | 1.91 | 36.53 | |
| 35 | Alcohol and Alcoholism | journal | 0.480 Q2 | 109 | 100 | 259 | 3638 | 385 | 244 | 1.27 | 36.38 | |
| 36 | Food and Chemical Toxicology | journal | 0.493 Q2 | 203 | 130 | 380 | 4609 | 558 | 372 | 1.30 | 35.45 | |
| 37 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.343 Q2 | 92 | 33 | 119 | 1167 | 129 | 119 | 1.42 | 35.36 | |
| 38 | Bioorganic and Medicinal Chemistry | journal | 0.864 Q1 | 187 | 321 | 688 | 11263 | 1245 | 687 | 1.78 | 35.09 | |
| 39 | Xenobiotica | journal | 0.534 Q2 | 89 | 93 | 297 | 3240 | 478 | 296 | 1.42 | 34.84 | |
| 40 | Journal of Toxicology and Environmental Health - Part A: Current Issues | journal | 0.483 Q2 | 99 | 114 | 168 | 3961 | 282 | 165 | 1.26 | 34.75 | |
| 41 | Clinical and Experimental Pharmacology and Physiology | journal | 0.580 Q2 | 115 | 209 | 626 | 7197 | 887 | 625 | 1.27 | 34.44 | |
| 42 | Immunopharmacology and Immunotoxicology | journal | 0.343 Q2 | 61 | 51 | 115 | 1749 | 103 | 115 | 0.81 | 34.29 | |
| 43 | Fundamental and Clinical Pharmacology | journal | 0.394 Q2 | 85 | 69 | 290 | 2303 | 284 | 288 | 0.84 | 33.38 | |
| 44 | Inhalation Toxicology | journal | 0.426 Q3 | 97 | 69 | 173 | 2281 | 189 | 172 | 0.90 | 33.06 | |
| 45 | Journal of Drug Targeting | journal | 0.666 Q1 | 107 | 49 | 134 | 1592 | 227 | 125 | 1.30 | 32.49 | |
| 46 | Journal of Liposome Research | journal | 0.331 Q2 | 64 | 41 | 122 | 1331 | 108 | 115 | 0.79 | 32.46 | |
| 47 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.242 Q3 | 81 | 63 | 184 | 2007 | 98 | 171 | 0.37 | 31.86 | |
| 48 | Journal of Autonomic Pharmacology | journal | 26 | 48 | 147 | 1511 | 176 | 147 | 0.71 | 31.48 | | |
| 49 | Chemical Biology and Drug Design | journal | 0.862 | 91 | 143 | 244 | 4445 | 416 | 242 | 1.70 | 31.08 | |
| 50 | Journal of Food Biochemistry | journal | 0.513 Q2 | 64 | 38 | 83 | 1154 | 61 | 83 | 0.69 | 30.37 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data